Ftse Mib
37.043,24
-0,21%
DAX
21.787,00
-0,58%
S&P 500
6.055,66
-0,46%
NASDAQ
19.580,76
-1,07%
Bitcoin
97.948,62
1,42%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zentalis Pharmaceuticals Inc (ZNTL) Zentalis Pharmaceuticals Inc (ZNTL) Notizie

Zentalis Pharmaceuticals Inc

ZNTL
1,995
-0,165 (-7,64%)
Ultimo aggiornamento: 18:59:37
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/2/202500:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202500:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202500:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:14EDGAR2Form 144 - Report of proposed sale of securities
04/2/202501:13EDGAR2Form 144 - Report of proposed sale of securities
03/2/202523:42GLOBEZentalis Pharmaceuticals Announces Inducement Grant Under..
29/1/202515:18EDGAR2Form 8-K - Current report
29/1/202513:00GLOBEZentalis Pharmaceuticals Shares Updated Clinical Data..
28/1/202522:07EDGAR2Form 8-K - Current report
28/1/202522:05GLOBEZentalis Pharmaceuticals Announces Strategic Restructuring..
09/1/202513:00GLOBEZentalis Pharmaceuticals Announces Azenosertib Fast Track..
03/1/202523:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:53GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
19/12/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
12/12/202413:00GLOBEZentalis Pharmaceuticals Announces Key Management..
04/12/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:35GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
13/11/202423:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202414:06EDGAR2Form 8-K - Current report
13/11/202414:00GLOBEZentalis Pharmaceuticals Announces Executive Leadership..
02/11/202400:04GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
05/10/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202403:38PRNUSKuehn Law Encourages Investors of Zentalis Pharmaceuticals,..
16/9/202413:02EDGAR2Form 8-K - Current report
16/9/202413:00GLOBEZentalis Pharmaceuticals Announces FDA Has Lifted Partial..
09/9/202413:00GLOBEZentalis Pharmaceuticals to Present Preclinical Azenosertib..
03/9/202422:40GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
19/8/202422:55BWNewman Ferrara LLP Announces Corporate Governance..
09/8/202413:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202413:01EDGAR2Form 8-K - Current report
09/8/202413:00GLOBEZentalis Pharmaceuticals Reports Second Quarter 2024..
02/8/202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
25/7/202420:49PRNUSKuehn Law Encourages Investors of Zentalis Pharmaceuticals,..
02/7/202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
18/6/202413:00GLOBEZentalis Pharmaceuticals Provides Update on Azenosertib..
04/6/202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
03/6/202413:00EDGAR2Form 8-K - Current report
30/5/202413:00GLOBEZentalis Pharmaceuticals to Present at the Jefferies Global..
29/5/202413:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202413:04EDGAR2Form 8-K - Current report
29/5/202413:00GLOBEZentalis Pharmaceuticals Announces Appointment of..
23/5/202423:01GLOBEZentalis Pharmaceuticals to Present Promising Results from..
14/5/202413:00GLOBEZentalis Pharmaceuticals to Present at TD Cowen 5th Annual..
07/5/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:03EDGAR2Form 8-K - Current report
07/5/202413:00GLOBEZentalis Pharmaceuticals Reports First Quarter 2024..
01/5/202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02/4/202422:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
01/4/202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
Apertura: 2,17 Min: 1,94 Max: 2,25
Chiusura: 2,16

La tua Cronologia

NASDAQ
ZNTL
Zentalis Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci